volume 19, issue 3, P165-173 2004
DOI: 10.1016/j.jcrc.2004.07.007
View full text
|
|
Share

Abstract: Because of improving antineoplastic treatment options with increasing cure rates, prolonging survival, and improving quality of life, the reluctance to admit patients with malignant disease to an intensive care unit is not justified; thus, the number of patients with malignancies treated in intensive care units rises. The use of more aggressive anticancer regimens leads to an increase of attendant infections, which are the most frequent and often life-threatening complications in cancer patients. A multidiscip…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
2
0
1

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals